Health Hippo: Drugs


US CODE
|| GAO ||
CASE LAW ||
NEWS || RELATED LINKS
The FDA Modernization Act dramatically
changes the regulation of drugs. Here are the links. To search the
entire Act, put your terms into
HippoSearch, then
use your browser's "find" command to pinpoint them on the retrieved
page(s).
TITLE I--IMPROVING
REGULATION OF DRUGS
- SUBTITLE A--FEES RELATING TO DRUGS
- SEC. 101.
Findings
- SEC. 102.
Definitions
- SEC. 103.
Authority to assess and use drug fees
- SEC. 104.
Annual reports
- SEC. 105.
Savings
- SEC. 106.
Effective date
- SEC. 107.
Termination of effectiveness
-
- SUBTITLE B--OTHER IMPROVEMENTS
- SEC. 111.
Pediatric studies of drugs
- SEC. 112.
Expediting study and approval of fast track drugs
- SEC. 113.
Information program on clinical trials for serious or
life-threatening diseases
- SEC. 114.
Health care economic information
- SEC. 115.
Clinical investigations
- SEC. 116.
Manufacturing changes for drugs
- SEC. 117.
Streamlining clinical research on drugs
- SEC. 118.
Data requirements for drugs and biologics
- SEC. 119.
Content and review of applications
- SEC. 120.
Scientific advisory panels
- SEC. 121.
Positron emission tomography
- SEC. 122.
Requirements for radiopharmaceuticals
- SEC. 123.
Modernization of regulation
- SEC. 124.
Pilot and small scale manufacture
- SEC. 125.
Insulin and antibiotics
- SEC. 126.
Elimination of certain labeling requirements
- SEC. 127.
Application of Federal law to practice of pharmacy compounding
- SEC. 128.
Reauthorization of clinical pharmacology program
- SEC. 129.
Regulations for sunscreen products
- SEC. 130.
Reports of postmarketing approval studies
- SEC. 131.
Notification of discontinuance of a life saving product
Antonio Benedi regularly drank 3 or 4 glasses
of wine during the week and sometimes more on weekends. In 1993,
Benedi was taking Extra-Strength Tylenol in regular doses for about 5
days when he fell into a coma and nearly died from liver and kidney
failure. Two days later, Benedi received an emergency liver
transplant. The physicians who examined Benedi's removed liver agreed
that the the damage was caused by acetaminophen toxicity and a jury
later awarded Benedi over $8 million in his lawsuit against
McNeil-P.P.C. The 4th U.S. Circuit Court of Appeals affirmed the
verdict in
BENEDI
v. MCNEIL-P.P.C., INC. Over the summer, Mr. Benedi moved into
commercials, starring in ads for rival Advil. See
All
About Health: The Problem With Pain Pills;
Global
NewsWeb: Whitehall-Robins Urges Consumers To Continue To Heed Warning
About Tylenol And Alcohol; Company Reaffirms Veracity Of Advil Ad
.
U.S. Code
GAO Reports
- Prescription
Drugs: Implications of Drug Labeling and Off-Label Use.
GAO/T-HEHS-96-212. 8 pp. Sept. 12, 1996.
- Medicaid:
Changes in Best Price for Outpatient Drugs Purchased by HMOs and
Hospitals (Fact Sheet, 08/05/94, GAO/HEHS-94-194FS). Congress
has tried to reduce Medicaid prescription drug costs by requiring
drug manufacturers to give state Medicaid programs rebates for
outpatient drugs.
- Nonprescription
Drugs: Value of a Pharmacist-Controlled Class Has Yet to Be
Demonstrated (Chapter Report, 08/24/95, GAO/PEMD-95-12) GAO
reviewed the creation of a drug class that would be available only
through pharmacies, but would not require a physician's
prescription.
- Pharmacy
Benefit Managers: Early Results on Ventures with Drug
Manufacturers (Letter Report, 11/09/95, GAO/HEHS-96-45). GAO
reviewed mergers between pharmacy benefit managers (PBM) and
pharmaceutical manufacturers.
- Prescription
Drugs and the Elderly: Many Still Receive Potentially Harmful
Drugs Despite Recent Improvements (Letter Report,
07/24/95,GAO/HEHS-95-152). GAO examined the elderly's
inappropriate use of prescription drugs.
- Prescription
Drugs: Automated Prospective Review Systems Offer Significant
Potential Benefits for Medicaid (Letter Report,
08/05/94,GAO/AIMD-94-130). Use of automatic systems linked to
statewide databases could provide a more thorough prospective
review than reviews based on manual or local systems.
- Prescription
Drugs: Spending Controls in Four European Countries (Chapter
Report, 05/17/94, GAO/HEHS-94-30). Although the United States
has traditionally allowed drug prices to be determined by the free
market, other countries use a variety of policies to control
prescription drug costs.
Cases
News & Reports
- FDA News
The latest from the Food and Drug Administration.
- Generic Drug Equity
Generic versions of some of this country's most widely prescribed
medicines will be kept off the market due to a Food and Drug
Administration (FDA) interpretation of a General Agreement on
Trade and Tariffs (GATT) Treaty provision.
- LEGAL
RESTRICTIONS ON THE ADVERTISING AND PROMOTION OF PHARMACEUTICAL
AND BIOLOGICAL PRODUCTS ON THE INTERNET There is thus little
to guide companies who are contemplating marketing over the
INTERNET and other new methods of electronic communication except
current laws, regulations, and regulatory guidance.
- Making
Your Voice Heard at FDA As a regulatory agency, FDA publishes
rules that establish or modify the way it regulates foods, drugs,
biologics, cosmetics, radiation- emitting electronic products, and
medical devices-- commodities close to the daily lives of all
Americans.
- Pharmacy Case
Review Pharmacy Case Review is a peer-reviewed, electronically
distributed journal dedicated to educational scholarship serving
as a curricular resource in pharmacy and related health care
education.
- Pharmoeconomics
Journal Lists the contents of past, current and future journal
articles.
- State
Marijuana Laws (a compilation of all the state laws relating
to marijuana possession)
- UConn
gopher: Biomedicine & Health in the news Indexes articles
from the New York Times and the Minneapolis Star-Tribune.
Related Links
Biotechnology Law
Web Server ~
DOD:
PharmacoEconomic Center Page ~
Drug
Enforcement Administration - Home Page ~
Drug
Information ~
Eli Lilly and Company ~
Medical
Sciences Bulletin ~
Merck & Co., Inc. ~
NEWSPAGE:
Pharmaceutical Industry ~
PCS Health Systems,
Inc. ~
Pharmaceutical Information
Network Home Page ~
Pharmaceutical
Reimbursement Assistance Programs ~
Pharmaceutical Research and
Manufacturers of America ~
PharmInfoNet:
Drug Database ~
PharmInfoNet:
DrugFAQs ~
PharmInfoNet:
DrugPR ~
PharmInfoNet:
sci.med.pharmacy Archive ~
Topics
in Clinical Biotechnology
HIPPOHOME //
HIPPONEWS //
HIPPOTALK // STILL
SEARCHING? //
TRAGICALLY HIPP
Health Hippo ©1996-2000: hippo@altavista.net